Drug profile · INN
macimorelin
GHRYVELIN (PREVIOUSLY MACIMORELIN AETERNA ZENTARIS)
macimorelin (GHRYVELIN (PREVIOUSLY MACIMORELIN AETERNA ZENTARIS)) is a ghrelin receptor agonist.
EMA: approved Various (V04) V04CD06
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — macimorelin
- Class
- Various (V04)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
macimorelin (GHRYVELIN (PREVIOUSLY MACIMORELIN AETERNA ZENTARIS)) is a ghrelin receptor agonist.
Key facts
INN macimorelin
Brand GHRYVELIN (PREVIOUSLY MACIMORELIN AETERNA ZENTARIS)
Mechanism Ghrelin receptor agonist
Target Growth hormone secretagogue receptor type 1
Therapeutic class Various (V04)
ATC code V04CD06
Mechanism of action
Ghrelin receptor agonist
Primary target: Growth hormone secretagogue receptor type 1
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is macimorelin?
macimorelin (GHRYVELIN (PREVIOUSLY MACIMORELIN AETERNA ZENTARIS)) is a ghrelin receptor agonist.
What is the brand name for macimorelin?
GHRYVELIN (PREVIOUSLY MACIMORELIN AETERNA ZENTARIS) is a marketed brand name for macimorelin. Check FDA Drugs@FDA for the current US label holder and prescribing information.